title: Oral contraceptives, replacement oestrogens and the risk of rheumatoid arthritis.
authors.affiliation: Harvard Medical School, Harvard School of Public Health, Boston, Massachusetts.
authors.forename: M
authors.initials: M
authors.lastname: Hernandez-Avila
authors.forename: M H
authors.initials: MH
authors.lastname: Liang
authors.forename: W C
authors.initials: WC
authors.lastname: Willett
authors.forename: M J
authors.initials: MJ
authors.lastname: Stampfer
authors.forename: G A
authors.initials: GA
authors.lastname: Colditz
authors.forename: B
authors.initials: B
authors.lastname: Rosner
authors.forename: R W
authors.initials: RW
authors.lastname: Chang
authors.forename: C H
authors.initials: CH
authors.lastname: Hennekens
authors.forename: F E
authors.initials: FE
authors.lastname: Speizer
mesh_terms: D000328:Adult; D001172:Arthritis, Rheumatoid / Q000453:epidemiology* / Q000517:prevention & control; D003278:Contraceptives, Oral, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D012307:Risk Factors; D014481:United States / Q000453:epidemiology
chemical_list: D003278:Contraceptives, Oral, Hormonal